Cholesterol News and Research

RSS

Cholesterol is a waxy, fat-like substance made in the liver, and found in the blood and in all cells of the body. Cholesterol is important for good health and is needed for making cell walls, tissues, hormones, vitamin D, and bile acid.

Health IT: Apps; Competitive contracts; Electronic medical records

The Wall Street Journal: "Indian technology companies are eyeing a coming wave of U.S. spending to digitize health care records. But sensitivity over outsourcing and resistance by American hospitals to sending medical information overseas could thwart efforts to win big contracts." Next year, the U.S. government will dispense billions to "health-care providers who adopt electronic medical records." Doctors are also facing "a federal mandate to upgrade software as the U.S. switches to a new system of insurance billing codes."

3 Nov 2010

Atrium completes enrollment in iCAST Atrium Registry Ultrasound Study

Atrium Medical Corporation is pleased to announce that the final patient was recently enrolled in the iCAST™ Atrium Registry Ultrasound Study (iCARUS). This study is a prospective, multi-center clinical trial studying the safety and efficacy of the Atrium iCAST™ Balloon Expandable Covered Stent in patients with occlusive disease of the iliac artery.

2 Nov 2010

Einstein College's new website features latest information on aging research

Albert Einstein College of Medicine of Yeshiva University has launched SuperAgers.com, a new website that features the latest information on more than a decade of aging research at Einstein.

2 Nov 2010

AGD encourages diabetic patients to pay attention to oral health

According to the U.S. Centers for Disease Control and Prevention, diabetes affects nearly 24 million people in the United States. In observance of National Diabetes Month, the Academy of General Dentistry (AGD) encourages those with diabetes to pay extra attention to their oral health.

2 Nov 2010

New findings pave way to improve early detection of ovarian cancer

A drug in testing to treat atherosclerosis significantly inhibited growth of ovarian cancer in both human cell lines and mouse models, the first such report of a peptide being used to fight malignancies, according to a study by researchers at UCLA's Jonsson Comprehensive Cancer Center.

2 Nov 2010

FDA approves cancer drug Afinitor for treatment of rare genetic disorder

The U.S. Food and Drug Administration approved the cancer drug Afinitor (everolimus) on Friday to treat patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS), a rare genetic disorder. This approval was for treatments of SEGA that can not be treated with surgery.

1 Nov 2010

First Edition: November 1, 2010

In today's health policy headlines, how will Tuesday's election impact the health law?

1 Nov 2010

Sugar in excess leads to complications

In light of Diabetes Awareness Month, many people are showing increased interest in the topic of sugar and sugar alternatives. With the various forms of sugar available table sugar, high-fructose corn syrup, agave, and honey understanding the differences between sugars and their effects on the body is not all sweet.

1 Nov 2010

HDMG and Heritage Health Care host over 4000 seniors at 20th anniversary of Health Expo

Dr. Richard Merkin, High Desert Medical Group and Heritage Health Care hosted over four thousand seniors at their 20th anniversary annual Senior Expo at the Antelope Valley Fairgrounds. Seniors lined up prior to the 9:00 am start, eager to see celebrity Debbie Reynolds perform and get free health screenings and testing including bone density, cholesterol, glucose, blood pressure, body fat, dental and vision screenings and of course, seasonal flu shots.

30 Oct 2010

HDL and Virginia governor announce $4.2 million investment for expanding operations

Health Diagnostic Laboratory (HDL, Inc.) and Governor Bob McDonnell have announced an investment of $4.2 million in HDL, Inc. operations, resulting in the creation of 213 new jobs in the City of Richmond. HDL, Inc., located in the Virginia BioTechnology Research Park, will expand its clinical laboratory, diagnostics and clinical trial services, as well as its physician/patient consulting.

30 Oct 2010

Alnylam to present data on RNAi therapeutics for fibrotic diseases at The Liver Meeting

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it will present several poster presentations at the 61st Annual Meeting of the American Association for the Study of Liver Diseases being held in Boston, Mass from October 29 - November 2, 2010.

30 Oct 2010

Dental health affects control of diabetes

Diabetes is a disease that affects every part of the body, and for people with unstable blood glucose levels there is a higher risk than normal for developing serious complications from poor oral hygiene. In a study by dLife, the world's largest diabetes community, and SoundView Research, Inc., 66 percent of active diabetes managers had not changed their oral care habits since being diagnosed and over half have not been advised by their dentist to take extra care to brush, floss, or rinse daily.

29 Oct 2010

Scientists identify potential new treatment for Nipah and Hendra viruses

Scientists at Weill Cornell Medical College have identified a potential new treatment for the Nipah and Hendra viruses, two lethal and emerging viruses for which there is currently no treatment or vaccine available. The approach could also lead to new therapies for measles, mumps and the flu. The new research appears in today's edition of the prestigious journal Public Library of Science (PLoS) Pathogens.

29 Oct 2010

With incentives from insurers, pharmacies refocus from snacks to drugs

Drug stores are returning to their roots — drugs, the (Raleigh N.C.) News and Observer/Scripps News reports. "After years of adding everything from groceries to grills to their inventory, drugstore chains are once again emphasizing their pharmacies.

29 Oct 2010

Chillies for diabetes: Study

Researchers from Tasmania, Australia are recruiting volunteers in a study to explore if eating chillies can help control lifestyle-related diabetes. At present they need 35 people with type 2 diabetes or glucose intolerance.

28 Oct 2010

Malvern Zetasizer Nano used to characterize environmentally responsive nanoparticles

The rapid, real-time measurement capabilities of the Zetasizer Nano system from Malvern Panalytical have enabled quantified nanoscale characterization of the environmental sensitivity of novel solubilization nanoparticles.

From Malvern Panalytical 28 Oct 2010

Preventive health programs reduce employee health risks

With employers and individuals continuing to struggle with rising health care costs, a new study shows there is one strategy that is proven to slow the pace of this ever increasing burden: preventive health. Published today in Population Health Management, "The Impact of The Prevention Plan on Employee Health Risk Reduction" reveals that prevention programs based on the clinical practice of preventive medicine are able to achieve measurable health risk reduction in just one year.

27 Oct 2010

Quebec recognizes value of ABILIFY for treating schizophrenia and related psychotic disorders

Bristol-Myers Squibb Canada is pleased to announce that Quebec has recognized the value of ABILIFY (aripiprazole) for the treatment of schizophrenia and related psychotic disorders in adults and has agreed to list ABILIFY as a reimbursed full benefit on the Quebec public drug plans as of October 14, 2010.

27 Oct 2010

Prevention of vascular diseases needed to avoid tsunami of cases

Canada urgently needs to focus on prevention of vascular diseases to avoid the burden from the expected tsunami of cases, says noted stroke expert Dr. Robert Côté, delivering the Heart and Stroke Foundation of Canada (HSFC) Lecture at the Canadian Cardiovascular Congress 2010.

26 Oct 2010

New source of blood-derived biomarkers may help in cancer diagnosis

The future of cancer diagnosis may lie in just a few milliliters of blood, according to a research team led by Professor Arie Admon of the Technion-Israel Institute of Technology.

26 Oct 2010